Alamar Biosciences Makes Market Debut with Shares Surging Over 34%

Stock News

04/18

Alamar Biosciences (ALMR.US) began trading on the U.S. stock market on Friday, with its share price opening more than 34% higher at $22.91. The IPO price was set at $17 per share. Alamar Biosciences is a biotechnology company based in California, focused on the development and application of precision proteomics technologies. The company's core products are built on its proprietary NULISA platform, which enables the detection of trace protein biomarkers in blood with extremely high sensitivity. This technology assists researchers in earlier disease detection and advances drug development and precision medicine. Its applications are primarily in the research of neurodegenerative diseases such as Alzheimer's and Parkinson's.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1111071379"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111071379\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111071379?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-18 00:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111071379","market":"us","top_or_hot":-1,"title":"Alamar Biosciences Makes Market Debut with Shares Surging Over 34%","media":"Stock News","content":"<p>Alamar Biosciences (ALMR.US) began trading on the U.S. stock market on Friday, with its share price opening more than 34% higher at $22.91. The IPO price was set at $17 per share. Alamar Biosciences is a biotechnology company based in California, focused on the development and application of precision proteomics technologies. The company's core products are built on its proprietary NULISA platform, which enables the detection of trace protein biomarkers in blood with extremely high sensitivity. This technology assists researchers in earlier disease detection and advances drug development and precision medicine. Its applications are primarily in the research of neurodegenerative diseases such as Alzheimer's and Parkinson's.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alamar Biosciences Makes Market Debut with Shares Surging Over 34%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlamar Biosciences Makes Market Debut with Shares Surging Over 34%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-04-18 00:38</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Alamar Biosciences (ALMR.US) began trading on the U.S. stock market on Friday, with its share price opening more than 34% higher at $22.91. The IPO price was set at $17 per share. Alamar Biosciences is a biotechnology company based in California, focused on the development and application of precision proteomics technologies. The company's core products are built on its proprietary NULISA platform, which enables the detection of trace protein biomarkers in blood with extremely high sensitivity. This technology assists researchers in earlier disease detection and advances drug development and precision medicine. Its applications are primarily in the research of neurodegenerative diseases such as Alzheimer's and Parkinson's.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALMR","symbol_name":"Alamar Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1111071379","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111071379","pubTimestamp":1776443894,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Alamar Biosciences (ALMR.US) began trading on the U.S. stock market on Friday, with its share price opening more than 34% higher at $22.91. The IPO price was set at $17 per share. Alamar Biosciences...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALMR":"Alamar Biosciences, Inc."},"translate_title":"Alamar Biosciences上市，股价飙升逾34%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALMR":1},"content_text":"Alamar Biosciences (ALMR.US) began trading on the U.S. stock market on Friday, with its share price opening more than 34% higher at $22.91. The IPO price was set at $17 per share. Alamar Biosciences is a biotechnology company based in California, focused on the development and application of precision proteomics technologies. The company's core products are built on its proprietary NULISA platform, which enables the detection of trace protein biomarkers in blood with extremely high sensitivity. This technology assists researchers in earlier disease detection and advances drug development and precision medicine. Its applications are primarily in the research of neurodegenerative diseases such as Alzheimer's and Parkinson's.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}